The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia

The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia

Christielly Rodrigues-Silva,1 Agostinho Tavares Semedo,1 Hiasmin Franciely da Silva Neri,1 Rosana Pereira Vianello,2 Carlos Galaviz-Hernández,3 Martha Sosa-Macías,3 Rodrigo Bernini de Brito,1,4 Paulo César Ghedini1 1Department of Pharmacology, Institute of Biological...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rodrigues-Silva C, Semedo AT, Neri HFS, Vianello RP, Galaviz-Hernández C, Sosa-Macías M, de Brito RB, Ghedini PC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
schizophrenia
cyp2c19*2
cyp2c19*17
treatment response
clozapine
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/a393e8f88f9d499b977944a7dc49c355
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a393e8f88f9d499b977944a7dc49c355

Ejemplares similares